Facility Type: Substance Use
- Medicare
- Medicaid
- Private health insurance
- Cash or self-payment
Type Of Care
- Substance use treatment
Opioid Medications Used In Treatment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
Type Of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder
External Source Of Medications Used For Alcohol Use Disorder Treatment
- In-network prescribing entity
- Other contracted prescribing entity
- No formal relationship with prescribing entity
Type Of Opioid Treatment
- Buprenorphine maintenance
- Prescribes buprenorphine
- Prescribes naltrexone
- Relapse prevention with naltrexone
Medication Therapy
- Acamprosate (Campral®)
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Buprenorphine (extended-release
- injectable)
- Naltrexone (oral)
- Naltrexone (extended-release
- injectable)
Treatment Approaches
- Telemedicine/telehealth therapy
Facility Operation Eg Private Public
- Private non-profit organization
License Certification Accreditation
- SAMHSA certification for opioid treatment program (OTP)
Assessment Pre Treatment
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for substance use
Testing
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
Transitional Services
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
Education And Counseling Services
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy
- Smoking permitted in designated area
Sex Accepted
- Female
- Male
Facility Vaping Policy
- Vaping permitted without restriction